Inventor · disambiguated record
Matthew M. Weiss
Also filed as: WEISS MATTHEW · WEISS MATTHEW M
47 granted patents·34 pending applications·368 citations·filing 2005–2025
98Inventor score
Top patents by PatentIndex Score
81 records- 0198US11723980B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Aug 15, 2023·9 cites·14 claims
- 0298US11117889B1IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2020·Granted Sep 14, 2021·28 cites·28 claims
- 0398US10874743B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2018·Granted Dec 29, 2020·38 cites·20 claims
- 0497US12258341B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2023·Granted Mar 25, 2025·5 cites·18 claims
- 0597US12168057B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2023·Granted Dec 17, 2024·5 cites·17 claims
- 0697US11807636B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Nov 7, 2023·6 cites·19 claims
- 0797US11707457B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Jul 25, 2023·11 cites·30 claims
- 0897US11292792B2Tricyclic CRBN ligands and uses thereofKYMERA THERAPEUTICS INC·Filed 2019·Granted Apr 5, 2022·19 cites·15 claims
- 0996US11779578B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2020·Granted Oct 10, 2023·7 cites·20 claims
- 1096US11591332B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2020·Granted Feb 28, 2023·9 cites·19 claims
- 1196US11358948B2CRBN ligands and uses thereofKYMERA THERAPEUTICS INC·Filed 2018·Granted Jun 14, 2022·16 cites·16 claims
- 1296US11352350B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2019·Granted Jun 7, 2022·20 cites·11 claims
- 1395US12091411B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2023·Granted Sep 17, 2024·5 cites·9 claims
- 1495US11318205B1IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2020·Granted May 3, 2022·10 cites·14 claims
- 1595US9663508B2Biaryl acyl-sulfonamide compounds as sodium channel inhibitorsAMGEN INC·Filed 2014·Granted May 30, 2017·29 cites·20 claims
- 1694US12150995B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2021·Granted Nov 26, 2024·4 cites·15 claims
- 1794US11932624B2MDM2 degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Mar 19, 2024·2 cites·30 claims
- 1894US8426447B2Spiro-tricyclic ring compounds as beta-secretase modulators and methods of useWHITE RYAN·Filed 2009·Granted Apr 23, 2013·58 cites·22 claims
- 1991US11897882B2Tricyclic crbn ligands and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Feb 13, 2024·1 cites·19 claims
- 2091US7435823B2Compounds and methods of useAMGEN INC·Filed 2005·Granted Oct 14, 2008·19 cites·23 claims
- 2190US11623932B2Protein degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2018·Granted Apr 11, 2023·3 cites·13 claims
- 2287US10383866B2Alkyl dihydroquinoline sulfonamide compoundsAMGEN INC·Filed 2016·Granted Aug 20, 2019·3 cites·37 claims
- 2387US2025000985A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2486US7872009B2Beta-Secretase modulators and methods of useAMGEN INC·Filed 2006·Granted Jan 18, 2011·11 cites·8 claims
- 2582US10729684B2Alkynyl dihydroquinoline sulfonamide compoundsAMGEN INC·Filed 2016·Granted Aug 4, 2020·3 cites·20 claims
- 2681US9776995B2Bicyclic sulfonamide compounds as sodium channel inhibitorsAMGEN INC·Filed 2014·Granted Oct 3, 2017·4 cites·24 claims
- 2781US8957083B2Spiro-amino-imidazolone and spiro-amino-dihydro-pyrimidinone compounds as beta-secretase modulators and methods of useMINATTI ANA ELENA·Filed 2011·Granted Feb 17, 2015·4 cites·19 claims
- 2880US9012443B2Bicyclic aryl and heteroaryl sodium channel inhibitorsAMGEN INC·Filed 2012·Granted Apr 21, 2015·6 cites·32 claims
- 2980US9012446B2Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of useAMGEN INC·Filed 2013·Granted Apr 21, 2015·4 cites·20 claims
- 3080US2025042902A1Tricyclic crbn ligands and uses thereofKYMERA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3179US11332459B2Benzimidazole derivatives and their usesTEIJIN PHARMA LTD·Filed 2018·Granted May 17, 2022·2 cites·16 claims
- 3278US8497264B2Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of useCHEN JIAN J·Filed 2011·Granted Jul 30, 2013·4 cites·29 claims
- 3377US9212182B2Bicyclic sulfonamide compounds as sodium channel inhibitorsAMGEN INC·Filed 2014·Granted Dec 15, 2015·3 cites·32 claims
- 3477US7745484B2Beta-secretase modulators and methods of useAMGEN INC·Filed 2006·Granted Jun 29, 2010·2 cites·15 claims
- 3576US10472356B2Bicyclic ketone sulfonamide compoundsAMGEN INC·Filed 2016·Granted Nov 12, 2019·3 cites·17 claims
- 3676US9458152B2Bicyclic sulfonamide compounds as sodium channel inhibitorsAMGEN INC·Filed 2015·Granted Oct 4, 2016·2 cites·18 claims
- 3776US8883782B2Spiro-tetracyclic ring compounds as beta-secretase modulators and methods of useCHENG YUAN·Filed 2011·Granted Nov 11, 2014·4 cites·18 claims
- 3876US2025011325A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3975US12454520B2Protein degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2019·Granted Oct 28, 2025·1 cites·16 claims
- 4075US2025214977A1Stat6 inhibitors and uses thereofKYMERA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4175US2025121073A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4275US2025325673A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4375US2023234953A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4474US2025163042A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4574US2025333417A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4673US9346827B25-amino-oxazepine and 5-amino-thiazepane compounds as beta secretase antagonists and methods of useDINEEN THOMAS·Filed 2012·Granted May 24, 2016·2 cites·14 claims
- 4773US2025388566A1Protein degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4873US2023115184A1Protein degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4972US7973047B2Beta-Secretase modulators and methods of useAMGEN INC·Filed 2010·Granted Jul 5, 2011·2 cites·21 claims
- 5071US9051311B2Sulfamide sodium channel inhibitorsAMGEN INC·Filed 2013·Granted Jun 9, 2015·1 cites·20 claims
Showing the top 50 of 81 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Matthew M. Weiss files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →